Matches in Wikidata for { <http://www.wikidata.org/entity/Q92794427> ?p ?o ?g. }
- Q92794427 description "2019 nî lūn-bûn" @default.
- Q92794427 description "2019年の論文" @default.
- Q92794427 description "2019年学术文章" @default.
- Q92794427 description "2019年学术文章" @default.
- Q92794427 description "2019年学术文章" @default.
- Q92794427 description "2019年学术文章" @default.
- Q92794427 description "2019年学术文章" @default.
- Q92794427 description "2019年学术文章" @default.
- Q92794427 description "2019年學術文章" @default.
- Q92794427 description "2019年學術文章" @default.
- Q92794427 description "2019年學術文章" @default.
- Q92794427 description "2019年學術文章" @default.
- Q92794427 description "2019年學術文章" @default.
- Q92794427 description "2019년 논문" @default.
- Q92794427 description "article científic" @default.
- Q92794427 description "article scientific" @default.
- Q92794427 description "article scientifique" @default.
- Q92794427 description "articol științific" @default.
- Q92794427 description "articolo scientifico" @default.
- Q92794427 description "artigo científico" @default.
- Q92794427 description "artigo científico" @default.
- Q92794427 description "artigo científico" @default.
- Q92794427 description "artikel ilmiah" @default.
- Q92794427 description "artikull shkencor" @default.
- Q92794427 description "artikulong pang-agham" @default.
- Q92794427 description "artykuł naukowy" @default.
- Q92794427 description "artículo científico publicado en 2019" @default.
- Q92794427 description "artículu científicu" @default.
- Q92794427 description "bilimsel makale" @default.
- Q92794427 description "bài báo khoa học" @default.
- Q92794427 description "naučni članak" @default.
- Q92794427 description "scienca artikolo" @default.
- Q92794427 description "scientific article published on 22 August 2019" @default.
- Q92794427 description "scientific article published on 22 August 2019" @default.
- Q92794427 description "scientific article published on 22 August 2019" @default.
- Q92794427 description "teaduslik artikkel" @default.
- Q92794427 description "tieteellinen artikkeli" @default.
- Q92794427 description "tudományos cikk" @default.
- Q92794427 description "vedecký článok" @default.
- Q92794427 description "vetenskaplig artikel" @default.
- Q92794427 description "videnskabelig artikel udgivet 22. august 2019" @default.
- Q92794427 description "vitenskapelig artikkel" @default.
- Q92794427 description "vitskapeleg artikkel" @default.
- Q92794427 description "vědecký článek" @default.
- Q92794427 description "wetenschappelijk artikel" @default.
- Q92794427 description "wissenschaftlicher Artikel" @default.
- Q92794427 description "επιστημονικό άρθρο" @default.
- Q92794427 description "мақолаи илмӣ" @default.
- Q92794427 description "наукова стаття, опублікована в серпні 2019" @default.
- Q92794427 description "научна статия" @default.
- Q92794427 description "научная статья" @default.
- Q92794427 description "научни чланак" @default.
- Q92794427 description "научни чланак" @default.
- Q92794427 description "מאמר מדעי" @default.
- Q92794427 description "مقالة علمية نشرت في 22 أغسطس 2019" @default.
- Q92794427 description "২২ আগস্ট ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q92794427 description "บทความทางวิทยาศาสตร์" @default.
- Q92794427 description "სამეცნიერო სტატია" @default.
- Q92794427 name "POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients" @default.
- Q92794427 name "POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients" @default.
- Q92794427 type Item @default.
- Q92794427 label "POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients" @default.
- Q92794427 label "POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients" @default.
- Q92794427 prefLabel "POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients" @default.
- Q92794427 prefLabel "POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients" @default.
- Q92794427 P1433 Q92794427-3C27B91D-517D-42DD-A13E-47ECFE9BF652 @default.
- Q92794427 P1476 Q92794427-1C086F72-2AD5-4776-AC84-4BB04519CAC4 @default.
- Q92794427 P2093 Q92794427-01D02896-8777-4BA8-A328-B202AF672513 @default.
- Q92794427 P2093 Q92794427-25A818C0-AEAA-4E6A-8585-179AD6736E8E @default.
- Q92794427 P2093 Q92794427-3D8031DC-6C48-4B82-9CFA-349251240DCE @default.
- Q92794427 P2093 Q92794427-4433B633-932E-4C52-9F39-5A2315602814 @default.
- Q92794427 P2093 Q92794427-47892811-B2D4-492C-946D-6B845CDC5848 @default.
- Q92794427 P2093 Q92794427-49BB50CE-D69A-40D1-8FAF-A91E910D4CB0 @default.
- Q92794427 P2093 Q92794427-63B2E04A-8119-4283-9669-9D5734EB62A0 @default.
- Q92794427 P2093 Q92794427-679272F2-3058-45C9-B3C1-64BD27B84643 @default.
- Q92794427 P2093 Q92794427-7A89DDF2-04E5-4A9C-9D0B-BB81FFA02C82 @default.
- Q92794427 P2093 Q92794427-863C261D-3FDF-41ED-9E1A-DE47EBD8E8F6 @default.
- Q92794427 P2093 Q92794427-A382AAE3-0345-4435-AE06-73F799DE029D @default.
- Q92794427 P2093 Q92794427-C2F7E5CF-8A1C-4378-861E-A24219908743 @default.
- Q92794427 P2093 Q92794427-C95A00A0-5A84-4B2C-9F4A-FFA5B67194A9 @default.
- Q92794427 P2093 Q92794427-CFA4022D-A72B-4A97-98E5-15E8AAEE4788 @default.
- Q92794427 P2093 Q92794427-DF9288E6-CD5E-4E11-9880-C4D7AE28D333 @default.
- Q92794427 P2093 Q92794427-E97DFA3F-F905-4805-B07D-0B6F7B57D63A @default.
- Q92794427 P2093 Q92794427-E995399C-00CA-4E91-B8DB-CDAF202069F2 @default.
- Q92794427 P304 Q92794427-72CF4FDF-ACA7-4F9D-9672-5A4EF4E40523 @default.
- Q92794427 P31 Q92794427-5D9E718B-31A3-496E-BF72-F7DF4A093452 @default.
- Q92794427 P356 Q92794427-851C4816-094D-4E2A-A88E-43DC29A0148C @default.
- Q92794427 P433 Q92794427-3236EA5E-CE74-4BE7-B134-257271297BD4 @default.
- Q92794427 P478 Q92794427-A615EE83-DCDE-4A01-B15D-5D5E273CECCC @default.
- Q92794427 P50 Q92794427-16576815-53EF-4870-A078-745B2CCD6E3E @default.
- Q92794427 P50 Q92794427-3AF86796-C36F-4138-A3A5-085C35CC1398 @default.
- Q92794427 P50 Q92794427-47CF8708-C87F-4FF9-B302-CC9F0C9AA420 @default.
- Q92794427 P50 Q92794427-600002E2-8B75-4AD4-A000-DEF0AA603E5D @default.
- Q92794427 P50 Q92794427-A9B4D427-FD38-4219-BCAD-2F7C2EE510E4 @default.
- Q92794427 P50 Q92794427-C4B4DEDC-6CD6-4904-84E4-5DB89A1B5CDC @default.
- Q92794427 P50 Q92794427-C4F4BE21-9165-4551-833C-DAD41DD6BE4C @default.
- Q92794427 P50 Q92794427-D4AB3251-5CCD-4D35-AEB7-F267E539C6D3 @default.
- Q92794427 P50 Q92794427-F2E59D85-EB42-4F8D-936B-9171AA760C6E @default.
- Q92794427 P50 Q92794427-F5F7541A-977A-42B7-9BDF-BD5692037A83 @default.
- Q92794427 P50 Q92794427-F7ED8265-B32C-4806-BE19-906BB51B2122 @default.